High-throughput testing for senior care
Diverse Panel Offerings
Diverse Panel Offerings
PRL has expanded beyond COVID-19 testing! We recently launched our Concise Respiratory Panel, with additional routine tests for general health in the pipline.
Early Variant Detection
Early Variant Detection
PRL's SARS-CoV-2 variant surveillance service, utilizing our advanced sequencing workflow, can identify SARS-CoV-2 variants in your patient population, a critical piece of information in shaping population-level mitigation and response.
Low Cost Burden
Low Cost Burden
Affordable GOLD standard PCR testing with fast turnaround times helps decrease unnecessary costs incurred from expensive, traditional diagnostics.
Regular Staff Testing
Regular Staff Testing
Test your staff regularly and easily to monitor cases within the facility, allowing you to take the appropriate action to mitigate transmission and protect your elderly residents.
Solutions for senior care
All-in-One Solution
All-in-One Solution
PRL provides integrated COVID-19 testing and variant surveillance sequencing, plus additional molecular testing for other infectious diseases, in one place.
Built for Scale
Built for Scale
PRL utilizes scientific and industry-leading lab automation expertise to process our tests at scale. We return 99% results in < 24 hours.
Accessibility
Accessibility
Price should not be the barrier to elevate the standard of care. Our services cost significantly less than the national average.
Proven Leadership
Proven Leadership
As NYC's official COVID-19 testing partner, PRL has tested millions of samples to date and was the first to detect Beta and Omicron variants in NY State.
Our offerings
Rapid response for isolation, quarantine and treatment decisions.
Quick rule-in or rule-out of infections with similar cold/flu-like symptoms.
Partner with us
FAQs
At present, our Rockville, MD lab can receive samples from all states except D.C., Pennsylvania, New York and Rhode Island.
At present, our Irvine, CA lab can receive samples from all states except Maryland, D.C., Pennsylvania, New York and Rhode Island.
Concise Panel
- SARS COV-2
- Influenza A
- Influenza B
- Respiratory Syncytial Virus
Comprehensive Panel
Virus
- SARS CoV-2
- Influenza A-pan
- Influenza A/H1N1
- Influenza A/H3
- Influenza A/H1N1 (2009)
- Influenza B
- RSV
- Human parainfluenzavirus 1
- Human parainfluenzavirus 2
- Human parainfluenzavirus 3
- Human parainfluenzavirus 4
- Coronavirus OC43
- Coronavirus 229E
- Coronavirus NL63
- Rhinovirus
- Adenovirus
- Human metapneumovirus
Bacteria
- Bordetella parapertussis
- Bordetella pertussis
- Chlamydia pneumoniae
- Mycoplasma pneumoniae
PRL can test for COVID-19 virus (SCV2) RNA in saliva and sample pools, as well as in nasal and nasopharyngeal swab transport media.
Unlike other laboratories, we can also sequence the SCV2 RNA detected to identify variants for public health and research purposes.
PRL has labs in New York City, Orange County and Washington D.C. PRL is exploring opening additional labs across the country.
Part number for the Concise Respiratory panel is 21000016. Part number for the Comprehensive panel is 21000001.
PRL has 3 CLIA-certified labs (PRL NY: 33D2196459, PRL DC: 21D2215498, PRL OC: 05D2230382)
PRL utilizes a proprietary scientific assay that can detect the presence of the SARS-CoV-2 virus with a limit of detection of 200 cp/mL while retaining gold standard industry accuracy.
Turnaround time (TAT) for 99% of tests between 6-24 hours.
PRL requires a minimum of 300 tests per day.